Stock Fundamentals

Company Information

▼
Company Name
Pmv Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US69353Y1038
CIK: 0001699382
CUSIP: 69353Y103
Currency: USD
Full Time Employees: 47
Phone: 609 642 6670
Website: https://www.pmvpharma.com
Fiscal Year End: December
IPO Date: Sep 25, 2020
Description:

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.

Address:

400 Alexander Park Drive, Princeton, NJ, United States, 08540

Directors & Officers

▼
Name Title Year Born
Dr. David H. Mack Ph.D. Co-Founder, CEO, President & Director 1962
Dr. Arnold J. Levine Ph.D. Co-Founder, Independent Director & Member of Scientific Advisory Board 1940
Mr. Michael Carulli Chief Financial Officer 1974
Dr. Deepika Jalota Pharm.D. Chief Development Officer 1977
Mr. Robert Ticktin J.D. General Counsel, COO & Company Secretary 1962
Mr. Tim Smith M.B.A. Senior VP and Head of Corporate Development & Investor Relations NA
Ms. Crystal Zuckerman Vice President of Human Resources NA
Dr. Binh Vu Ph.D. Senior Vice President of Drug Discovery & CMC NA
Dr. Marc Fellous M.D. Senior VP and Head of Clinical Development & Medical Affairs NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Orbimed Advisors, LLC 5.98M Sep 30, 2025 11.23% $0.20 -7.72%
BML Capital Management LLC 5.29M Dec 31, 2025 9.95% $5.72 0.00%
TANG CAPITAL MANAGEMENT LLC 4.79M Sep 30, 2025 8.99% $0.26 0.00%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 3.09M Dec 31, 2025 5.81% $0.09 -6.40%
Sio Capital Management, LLC 2.64M Sep 30, 2025 4.95% $0.93 -29.42%
Euclidean Capital LLC 2.63M Sep 30, 2025 4.94% $1.55 0.00%
Vanguard Group Inc 2.17M Dec 31, 2025 4.08% $0.00 0.34%
Acadian Asset Management LLC 2.07M Sep 30, 2025 3.88% $0.01 0.00%
Stonepine Capital Management Llc 1.15M Dec 31, 2025 2.16% $1.05 -16.01%
BlackRock Inc 1.10M Sep 30, 2025 2.08% $0.00 -3.20%
Two Sigma Advisers, LLC 874.10K Dec 31, 2025 1.64% $0.00 109.16%
Two Sigma Investments LLC 706.06K Dec 31, 2025 1.33% $0.00 161.87%
Marshall Wace Asset Management Ltd 612.63K Sep 30, 2025 1.15% $0.00 0.00%
Jacobs Levy Equity Management, Inc. 524.35K Dec 31, 2025 0.99% $0.00 663.60%
Aldebaran Capital LLC 477.99K Dec 31, 2025 0.90% $0.54 -5.19%
Geode Capital Management, LLC 431.82K Sep 30, 2025 0.81% $0.00 -0.20%
Bridgeway Capital Management, LLC 428.85K Dec 31, 2025 0.81% $0.01 33.74%
Jane Street Group LLC 382.05K Sep 30, 2025 0.72% $0.00 0.00%
Northern Trust Corp 380.81K Sep 30, 2025 0.72% $0.00 229.26%
Walleye Trading Advisors, LLC 335.69K Dec 31, 2025 0.63% $0.00 20.55%

Shares Statistics

▼
Shares Outstanding: 53.21M
Shares Float: 46.25M
% Insiders: 329.00%
% Institutions: 6,123.10%
Short % Float: 2.73%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Orbimed Advisors, LLC 5.98M 11.23% ▼ 7.72% Sep 30, 2025
2 BML Capital Management LLC 5.29M 9.95% ▲ 0.00% Dec 31, 2025
3 TANG CAPITAL MANAGEMENT LLC 4.79M 8.99% ▲ 0.00% Sep 30, 2025
4 ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 3.09M 5.81% ▼ 6.40% Dec 31, 2025
5 Sio Capital Management, LLC 2.64M 4.95% ▼ 29.42% Sep 30, 2025
6 Euclidean Capital LLC 2.63M 4.94% ▲ 0.00% Sep 30, 2025
7 Vanguard Group Inc 2.17M 4.08% ▲ 0.34% Dec 31, 2025
8 Acadian Asset Management LLC 2.07M 3.88% ▲ 0.00% Sep 30, 2025
9 Stonepine Capital Management Llc 1.15M 2.16% ▼ 16.01% Dec 31, 2025
10 BlackRock Inc 1.10M 2.08% ▼ 3.20% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $-44.24M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $84.07M
EBITDA: $-86.07M
Book Value: $1.96
Earnings/Share: $-1.59
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -35.00%
ROE (TTM): -55.37%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 10.09x 0.00x 0.10x N/A 0.00x
2024-12-31 12.22x 0.00x 0.08x N/A 0.00x
2023-12-31 14.78x 0.00x 0.10x N/A -0.01x
2022-12-31 22.80x 0.00x 0.09x -19.12x -0.01x
2021-12-31 24.66x 0.00x 0.07x -75.02x -0.01x
2020-12-31 56.90x 0.00x 0.02x -42.30x 0.00x
2019-12-31 22.57x 0.00x 1.68x -20.60x 0.00x
2018-12-31 26.75x 0.00x 1.73x N/A 0.00x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Oct 23, 2025 Orbimed Advisors Llc N/A Sale 1.00M $1.52 $1.52M
Sep 10, 2025 Orbimed Advisors Llc N/A Sale 500.00K $1.80 $900.00K
Jul 01, 2025 David Henry Mack N/A Sale 58.41K $1.06 $61.92K
Jul 01, 2025 Deepika Jalota N/A Sale 33.07K $1.06 $35.05K
Jul 01, 2025 Robert Ticktin N/A Sale 23.15K $1.06 $24.54K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PMVP.US!